Tikhonova Maria, Kulikov Alexander V
Institute of Cytology and Genetics, Siberian Branch of Russian Academy of Sciences, Lavrentyev Ave., 10, Novosibirsk 630090, Russia.
Chin J Physiol. 2012 Aug 31;55(4):284-93. doi: 10.4077/CJP.2012.BAA041.
Although numerous data evidence the implication of brain-derived neurotrophic factor (BDNF) in the pathophysiology of depression, the potential for BDNF to correct genetically defined depressive-like states is poorly studied. This study was aimed to reveal antidepressant-like effects of BDNF (300 ng, 2×, i.c.v.) on behavior and mRNA expression of genes associated with depression-like state in the brain in mice of antidepressant sensitive catalepsy (ASC) strain characterized by high hereditary predisposition to catalepsy and depressive-like features. Behavioral tests were held on the 7th-16th days after the first (4th-13th after the second) BDNF injection. Results showed that BDNF normalized impaired sexual motivation in the ASC males, and this BDNF effect differed, with advantageous effects, from that of widely used antidepressants. The anticataleptic effect of two BDNF injections was enhanced compared with a single administration. A tendency to decrease the immobility duration in tail-suspension test was observed in BDNF-treated ASC mice. The effects on catalepsy and sexual motivation were specific since BDNF did not alter locomotor and exploratory activity or social interest in the ASC mice. Along with behavioral antidepressant-like effects on the ASC mice, BDNF increased hippocampal mRNA levels of Bdnf and Creb1 (cAMP response element-binding protein gene). BDNF also augmented mRNA levels of Arc gene encoding Arc (Activity-regulated cytoskeleton-associated) protein involved in BDNF-induced processes of neuronal and synaptic plasticity in hippocampus and prefrontal cortex. The data suggest that: [1] BDNF is effective in the treatment of some genetically defined behavioral disturbances; [2] BDNF influences sexually-motivated behavior; [3] Arc mRNA levels may serve as a molecular marker of BDNF physiological activity associated with its long-lasting behavioral effects; [4] ASC mouse strain can be used as a suitable model to study mechanisms of BDNF effects on hereditary-dependent behavioral disorders.
尽管大量数据证明脑源性神经营养因子(BDNF)与抑郁症的病理生理学有关,但BDNF纠正基因定义的抑郁样状态的潜力却鲜有研究。本研究旨在揭示BDNF(300 ng,2次,脑室内注射)对具有抗抑郁药敏感性僵住症(ASC)品系小鼠行为及与脑内抑郁样状态相关基因mRNA表达的抗抑郁样作用,该品系小鼠对僵住症和抑郁样特征具有高度遗传易感性。行为测试在首次(第二次注射后第4 - 13天)BDNF注射后的第7 - 16天进行。结果显示,BDNF使ASC雄性小鼠受损的性动机恢复正常,且这种BDNF效应与广泛使用的抗抑郁药不同,具有有利影响。与单次给药相比,两次BDNF注射的抗僵住症作用增强。在接受BDNF治疗的ASC小鼠中观察到悬尾试验中不动时间有缩短趋势。BDNF对僵住症和性动机的影响具有特异性,因为它未改变ASC小鼠的运动和探索活动或社交兴趣。除了对ASC小鼠具有行为抗抑郁样作用外,BDNF还增加了海马中Bdnf和Creb1(环磷酸腺苷反应元件结合蛋白基因)的mRNA水平。BDNF还提高了Arc基因的mRNA水平,该基因编码参与海马体和前额叶皮质中BDNF诱导的神经元和突触可塑性过程的Arc(活性调节细胞骨架相关)蛋白。数据表明:[1] BDNF在治疗某些基因定义的行为障碍方面有效;[2] BDNF影响性动机行为;[3] Arc mRNA水平可作为与其长期行为效应相关的BDNF生理活性的分子标志物;[4] ASC小鼠品系可作为研究BDNF对遗传性依赖行为障碍作用机制的合适模型。